H Stewart Parker - Net Worth and Insider Trading
H Stewart Parker Net Worth
The estimated net worth of H Stewart Parker is at least $25,221 dollars as of 2024-04-28. H Stewart Parker is the Director of Sangamo Therapeutics Inc and owns about 48,700 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $25,217. H Stewart Parker is also the Director of Achieve Life Sciences Inc and owns about 1 shares of Achieve Life Sciences Inc (ACHV) stock worth over $5. Details can be seen in H Stewart Parker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that H Stewart Parker has not made any transactions after 2022-06-01 and currently still holds the listed stock(s).
Transaction Summary of H Stewart Parker
H Stewart Parker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H Stewart Parker owns 5 companies in total, including Sangamo Therapeutics Inc (SGMO) , Achieve Life Sciences Inc (ACHV) , and Armata Pharmaceuticals Inc (ARMP) among others .
Click here to see the complete history of H Stewart Parker’s form 4 insider trades.
Insider Ownership Summary of H Stewart Parker
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SGMO | Sangamo Therapeutics Inc | 2022-06-01 | director |
ACHV | Achieve Life Sciences Inc | 2011-08-09 | director |
ARMP | Armata Pharmaceuticals Inc | 2019-05-09 | director |
IMPLQ | IPI Legacy Liquidation Co | 2021-04-22 | director |
CDXS | Codexis Inc | 2022-12-16 | director |
H Stewart Parker Latest Holdings Summary
H Stewart Parker currently owns a total of 2 stocks. Among these stocks, H Stewart Parker owns 48,700 shares of Sangamo Therapeutics Inc (SGMO) as of June 1, 2022, with a value of $25,217 and a weighting of 99.98%. H Stewart Parker also owns 1 shares of Achieve Life Sciences Inc (ACHV) as of August 9, 2011, with a value of $5 and a weighting of 0.02%.
Latest Holdings of H Stewart Parker
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGMO | Sangamo Therapeutics Inc | 2022-06-01 | 48,700 | 0.52 | 25,217 |
ACHV | Achieve Life Sciences Inc | 2011-08-09 | 1 | 4.61 | 5 |
Holding Weightings of H Stewart Parker
H Stewart Parker Form 4 Trading Tracker
According to the SEC Form 4 filings, H Stewart Parker has made a total of 2 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sangamo Therapeutics Inc is the acquisition of 5,000 shares on June 1, 2022, which cost H Stewart Parker around $18,000.
According to the SEC Form 4 filings, H Stewart Parker has made a total of 0 transactions in Achieve Life Sciences Inc (ACHV) over the past 5 years. The most-recent trade in Achieve Life Sciences Inc is the acquisition of 1 shares on August 9, 2011, which cost H Stewart Parker around $30,270.
Insider Trading History of H Stewart Parker
- 1
H Stewart Parker Trading Performance
GuruFocus tracks the stock performance after each of H Stewart Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H Stewart Parker is 22.17%. GuruFocus also compares H Stewart Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by H Stewart Parker within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H Stewart Parker's insider trading performs compared to the benchmark.
Performance of H Stewart Parker
Average Return
9.46%
Outperforming Transactions
40%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 15.04 | 22.17 | 19.57 | 9.46 | -2.12 | -17.8 |
Relative Return to S&P 500(%) | 13.38 | 17.22 | 8.82 | -11.36 | -22.36 | -35.89 |
H Stewart Parker Ownership Network
Ownership Network List of H Stewart Parker
Ownership Network Relation of H Stewart Parker
H Stewart Parker Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
H Stewart Parker is the director of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, H Stewart Parker made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
H Stewart Parker Mailing Address
Above is the net worth, insider trading, and ownership report for H Stewart Parker. Currently GuruFocus does not have mailing address information for H Stewart Parker.